E 275mg / H 75mg / Z 400mg / R 150mg, tab., blister

STD DORAEHZR2T1

Valid Article

Former Code(s): -X DORARHZE1FD
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit. A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

ETHAMBUTOL / ISONIAZID / PYRAZINAMIDE / RIFAMPICIN

Full Name

Therapeutic Action

Fixed-dose combination (FDC) of three antituberculosis bactericidals and one antituberculosis bacteriostatic (ethambutol)

Indications

Drug-Sensitive tuberculosis (DS-TB)

Instructions for use

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per tablet, not per blister.

Storage

Below 25ºC ‐ Protect from sunlight ‐ Protect from humidity